RARE Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.

$62.65  +2.99 (5.01%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/31/2014
Outstanding shares:  69,930,191
Average volume:  522,248
Market cap:   $4,172,035,195
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ62Z18
Valuation   (See tab for details)
PE ratio:   -9.32
PB ratio:   5.49
PS ratio:   12.57
Return on equity:   -59.04%
Net income %:   -141.65%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy